345 related articles for article (PubMed ID: 37767098)
1. Noncoding RNAs as an emerging resistance mechanism to immunotherapies in cancer: basic evidence and therapeutic implications.
Wang M; Yu F; Li P
Front Immunol; 2023; 14():1268745. PubMed ID: 37767098
[TBL] [Abstract][Full Text] [Related]
2. Noncoding RNAs: the shot callers in tumor immune escape.
Liu L; Wang Q; Qiu Z; Kang Y; Liu J; Ning S; Yin Y; Pang D; Xu S
Signal Transduct Target Ther; 2020 Jun; 5(1):102. PubMed ID: 32561709
[TBL] [Abstract][Full Text] [Related]
3. Noncoding RNAs as novel immunotherapeutic tools against cancer.
Kaur M; Kaur B; Konar M; Sharma S
Adv Protein Chem Struct Biol; 2022; 129():135-161. PubMed ID: 35305717
[TBL] [Abstract][Full Text] [Related]
4. Targeting non-coding RNAs to overcome cancer therapy resistance.
Chen B; Dragomir MP; Yang C; Li Q; Horst D; Calin GA
Signal Transduct Target Ther; 2022 Apr; 7(1):121. PubMed ID: 35418578
[TBL] [Abstract][Full Text] [Related]
5. Noncoding RNAs in cancer and cancer stem cells.
Huang T; Alvarez A; Hu B; Cheng SY
Chin J Cancer; 2013 Nov; 32(11):582-93. PubMed ID: 24206916
[TBL] [Abstract][Full Text] [Related]
6. The interplay between non-coding RNAs and alternative splicing: from regulatory mechanism to therapeutic implications in cancer.
Liu M; Zhang S; Zhou H; Hu X; Li J; Fu B; Wei M; Huang H; Wu H
Theranostics; 2023; 13(8):2616-2631. PubMed ID: 37215575
[TBL] [Abstract][Full Text] [Related]
7. Noncoding RNAs in cancer therapy resistance and targeted drug development.
Wang WT; Han C; Sun YM; Chen TQ; Chen YQ
J Hematol Oncol; 2019 Jun; 12(1):55. PubMed ID: 31174564
[TBL] [Abstract][Full Text] [Related]
8. Noncoding RNAs as potential mediators of resistance to cancer immunotherapy.
Vishnubalaji R; Shaath H; Elango R; Alajez NM
Semin Cancer Biol; 2020 Oct; 65():65-79. PubMed ID: 31733291
[TBL] [Abstract][Full Text] [Related]
9. The role of noncoding RNAs and sirtuins in cancer drug resistance.
Zahedipour F; Jamialahmadi K; Karimi G
Eur J Pharmacol; 2020 Jun; 877():173094. PubMed ID: 32243871
[TBL] [Abstract][Full Text] [Related]
10. Functions of non-coding RNAs in regulating cancer drug targets.
Chai B; Ma Z; Wang X; Xu L; Li Y
Acta Biochim Biophys Sin (Shanghai); 2022 Mar; 54(3):279-291. PubMed ID: 35538038
[TBL] [Abstract][Full Text] [Related]
11. The Potential Role of circRNA in Tumor Immunity Regulation and Immunotherapy.
Xu Z; Li P; Fan L; Wu M
Front Immunol; 2018; 9():9. PubMed ID: 29403493
[TBL] [Abstract][Full Text] [Related]
12. Noncoding RNAs in DNA Damage Response: Opportunities for Cancer Therapeutics.
Arjumand W; Asiaf A; Ahmad ST
Methods Mol Biol; 2018; 1699():3-21. PubMed ID: 29086365
[TBL] [Abstract][Full Text] [Related]
13. Noncoding RNAs in esophageal cancer: A glimpse into implications for therapy resistance.
Yang Z; Ma R; Li J; Zhao L
Pharmacol Res; 2023 Feb; 188():106678. PubMed ID: 36709789
[TBL] [Abstract][Full Text] [Related]
14. The interplay between m6A modification and non-coding RNA in cancer stemness modulation: mechanisms, signaling pathways, and clinical implications.
Qin S; Mao Y; Wang H; Duan Y; Zhao L
Int J Biol Sci; 2021; 17(11):2718-2736. PubMed ID: 34345203
[TBL] [Abstract][Full Text] [Related]
15. The potential of BRAF-associated non-coding RNA as a therapeutic target in melanoma.
Fattore L; Mancini R; Ascierto PA; Ciliberto G
Expert Opin Ther Targets; 2019 Jan; 23(1):53-68. PubMed ID: 30507327
[TBL] [Abstract][Full Text] [Related]
16. The promising role of noncoding RNAs in cancer-associated fibroblasts: an overview of current status and future perspectives.
Fang Z; Xu J; Zhang B; Wang W; Liu J; Liang C; Hua J; Meng Q; Yu X; Shi S
J Hematol Oncol; 2020 Nov; 13(1):154. PubMed ID: 33213510
[TBL] [Abstract][Full Text] [Related]
17. Noncoding RNAs in cancer immunity: functions, regulatory mechanisms, and clinical application.
Zhang L; Xu X; Su X
Mol Cancer; 2020 Mar; 19(1):48. PubMed ID: 32122338
[TBL] [Abstract][Full Text] [Related]
18. Roles of noncoding RNAs in drug resistance in multiple myeloma.
Li J; Zou J; Wan X; Sun C; Chu Z; Hu Y
J Cell Physiol; 2020 Nov; 235(11):7681-7695. PubMed ID: 32324301
[TBL] [Abstract][Full Text] [Related]
19. Non-coding RNAs as Novel Biomarkers in Cancer Drug Resistance.
Yang H; Qi C; Li B; Cheng L
Curr Med Chem; 2022; 29(5):837-848. PubMed ID: 34348605
[TBL] [Abstract][Full Text] [Related]
20. Noncoding RNAs in pyroptosis and cancer progression: Effect, mechanism, and clinical application.
Zhang M; Dang P; Liu Y; Qiao B; Sun Z
Front Immunol; 2022; 13():982040. PubMed ID: 36059539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
